Levofloxacin + Ornidazole Tablets â€“ Advanced Dual-Action Antibacterial Therapy

Levofloxacin + Ornidazole Tablets are an advanced dual-action antibacterial formulation designed to effectively treat mixed bacterial and protozoal infections. This combination pairs the potent fluoroquinolone Levofloxacin with the nitroimidazole derivative Ornidazole for broader therapeutic coverage. It is widely used in gastrointestinal, dysentery, diarrhea, and intra-abdominal infection management. The dual mechanism helps target aerobic bacteria, anaerobic organisms, and protozoa in a single therapy. Manufactured in compliance with international pharmaceutical standards, it offers reliable efficacy, safety, and global market suitability.

Levofloxacin + Ornidazole Tablets represent an effective solution for infections involving both aerobic bacteria and anaerobic or protozoal organisms. Levofloxacin works by inhibiting bacterial DNA replication, while Ornidazole targets anaerobic bacteria and protozoa. This synergistic action enhances clinical effectiveness in mixed infections. Available in 250mg + 500mg strength for balanced and flexible treatment. Widely accepted in modern antibacterial therapy protocols.

Request Quote

Overview

Dual-action antibacterial and antiprotozoal tablet formulation.
Combines Levofloxacin and Ornidazole for broader pathogen coverage.
Widely used for gastrointestinal and mixed infections.
Suitable for hospital and outpatient clinical use.
Designed for global pharmaceutical distribution.

Introduction

Levofloxacin + Ornidazole Tablets represent an effective solution for infections involving both aerobic bacteria and anaerobic or protozoal organisms.
Levofloxacin works by inhibiting bacterial DNA replication, while Ornidazole targets anaerobic bacteria and protozoa.
This synergistic action enhances clinical effectiveness in mixed infections.
Available in 250mg + 500mg strength for balanced and flexible treatment.
Widely accepted in modern antibacterial therapy protocols.

Important Information

Primarily indicated for mixed bacterial and protozoal infections.
Useful in gastrointestinal infections such as diarrhea and dysentery.
Effective in amoebiasis and anaerobic bacterial infections.
Provides broad-spectrum coverage with dual mechanism of action.
Meets international quality standards such as USP, BP, and IP.

Dosage

General

Standard dosage: 1 tablet (250mg + 500mg) once or twice daily
Treatment duration usually ranges from 5 to 10 days
Dosage depends on infection severity and patient condition

Administration

Taken orally with water
Preferably taken with or after meals
Follow the prescribed schedule strictly

Important

Complete the full treatment course
Avoid skipping doses
Use only under medical supervision

Storage

Store below 25Â°C
Protect from light and moisture
Keep in original packaging
Avoid extreme environmental conditions

Shelf Life

Typical shelf life: 24 months
Depends on active ingredient stability and packaging integrity
Manufactured under ICH-guided stability protocols
Check expiry before use

Manufacturing

Manufactured in WHO-GMP certified facilities
High-quality API sourcing
Precision blending and tablet compression
Strict quality control testing
Compliance with international pharmacopeial standards
Export-ready packaging and documentation support

Precautions

Avoid use in patients hypersensitive to quinolones or nitroimidazoles
Use cautiously in liver or kidney disorders
Avoid alcohol during treatment
Not recommended for children unless prescribed
Use under medical supervision only

Side Effects

Nausea
Diarrhea
Dizziness
Headache
Metallic taste
Rare allergic reactions

Expert View

This combination provides a strategic advantage in mixed infection management.
It offers broad pathogen coverage with fast symptom relief.
Widely valued for dual-action effectiveness and patient compliance.
Suitable for both hospital and outpatient treatment settings.
Represents a strong option in global antibacterial therapy.

Indications

Gastrointestinal infections
Diarrhea and dysentery
Amoebiasis and protozoal infections
Mixed bacterial-protozoal infections
Intra-abdominal infections
Anaerobic bacterial infections

Maintenance

Follow prescribed dose and treatment duration strictly
Complete the full course even if symptoms improve early
Maintain hydration during treatment
Avoid self-medication and unnecessary repeat use
Consult a healthcare professional if symptoms persist

Why Choose

Dual-action antibacterial and antiprotozoal effectiveness
Broad pathogen coverage
Fast symptomatic relief
Strong global demand and acceptance
WHO-GMP compliant manufacturing

Frequently Asked Questions

Common product and supply questions.

What is levofloxacin and ornidazole used for?+

Levofloxacin + Ornidazole Tablets are used to treat gastrointestinal infections, diarrhea, dysentery, and mixed bacterial-protozoal infections. This combination provides broad-spectrum coverage and is widely prescribed for effective infection management.

Is ornidazole a strong antibiotic?+

Ornidazole is an effective antimicrobial agent active against anaerobic bacteria and protozoa. When combined with Levofloxacin, it enhances the overall effectiveness of this dual-action therapy in complex infections.

Which bacteria is killed by levofloxacin?+

Levofloxacin targets a wide range of gram-positive and gram-negative bacteria by inhibiting DNA replication, making the combination effective against various susceptible bacterial infections.

Can levofloxacin cause loose motion?+

Yes, Levofloxacin + Ornidazole Tablets may cause mild gastrointestinal side effects such as diarrhea or loose motion. These effects are usually temporary but should be monitored if they persist.

Is levofloxacin a very strong antibiotic?+

Levofloxacin is considered a strong broad-spectrum antibiotic effective against many resistant bacterial strains. In combination with Ornidazole, its therapeutic coverage becomes even more comprehensive.